Search results

ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.  

A large international team has provided an understanding of how nanoscale interactions affect the thermal stability of a type of next generation organic solar cells.

An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.

ANSTO’s Innovation Precinct has been highlighted in the Greater Sydney Commission’s South District Plan.

Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.

Researchers use Kitaev theoretical model to explain unusual phenomenon in two-dimensional material.

Below lists some useful programs for data reduction, search matching, analysis and structure visualisation of diffraction data.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.

The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.

Lutetium-177 used for advanced prostate cancer

Letter to Editor of the Sydney Morning Herald following publication of news report